Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare Expands CareVention HealthCare Offerings with the Addition of PersonifilRx and Pharmastar
“For many years we worked closely with the Personica team to serve the pharmacy needs of our PACE clients, and we have long admired the highly-respected business their team built,” said TRHC Chairman and CEO, Calvin
In addition to the extensive compliance requirements, CMS performs financial audits on at least one third of all Part D plans each year and encourages PACE programs to engage third parties to help with oversight and administration of their plans. Personica’s Part D solutions are designed to satisfy these demands and include: Medicare and state reporting requirements, claims processing, fraud, waste and abuse monitoring, and drug utilization review programs.
Personica CEO, Peter Farrow, noted, “The synergy of the tools brought together by TRHC will benefit both new and existing PACE plans, and more importantly, the members they serve. The PACE market will continue to grow at healthy rates as its value-based model delivers outstanding results in its mission of caring for the elderly. This is an exciting development for TRHC, our team, and PACE.”
TRHC management will provide additional details of the Personica acquisition during TRHC’s third quarter 2020 earnings call on
TRHC is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, pharmacist providers and other healthcare organizations. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. These forward-looking statements include, among other things, our goals and expectations regarding the acquisition and the integration of Personica into TRHC, the expected synergies from the combined company and the expected financial and operating performance of TRHC following the completion of the acquisition. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the risk that we may not be able to achieve our expectations with respect to the acquisition due to challenges in integration and inability to retain key employees; fluctuations in our financial results; the acceptance and use of our products and services by PACE organizations and pharmacies; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the
|TRHC Media Contact
T: (856) 912-5714
T: (215) 870-0829
|TRHC Investor Contact
T: (866) 648-2767
Source: Tabula Rasa HealthCare, Inc.